Explore how AI in high-throughput screening improves drug discovery through advanced data analysis, hit identification and ...

In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...

Can automation solve the bottlenecks in immunogenicity testing? Dr. Rob Dodge explains the role of robotics and machine learning in scaling NAb assays.

Head and neck cancers represent a biologically heterogeneous group of malignancies requiring accurate diagnosis, staging, and risk stratification for ...